The Supreme Cannabis Company (FIRE.T) made its first shipment of medical cannabis to Australia today, according to a press release.
The shipment is a private label transaction where their medical cannabis will be sold in 10-gram containers and distributed to patients across the country.
“We are pleased to be introducing our medical cannabis to the Australian market. Having already completed shipments to Israel, our first sale into the Australian market is a meaningful step toward executing on our international medical strategy of creating additional wholesale medical partnerships in various international jurisdictions. We are committed to supplying high-quality medical cannabis to our partners; Australian patients will now be able to access our Jean Guy strain, which is a tribute to the legendary variety offered by the Montreal Compassion Club. We are impressed by the significant growth of the Australian medical cannabis market and we look forward to opportunities to expand our Australian partnership and help more Australian patients in 2021,” said Beena Goldenberg, president and CEO of Supreme Cannabis.
Supreme is trading presently at $0.18 on relatively flat trading, although it’s early in the day at the time of writing, so that may change.
The move into Australia is significant because the Australian medical market has been growing steadily, and in fact expected to triple due to active patients and prodcut sales measured by revenue, according to FreshLeafAnalystics’ Australian Medicinal Cannabis Market Patient and Pricing Analysis for Q3 2020.
—Joseph Morton
